News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
327,059 Results
Type
Article (19555)
Company Profile (139)
Press Release (307365)
Section
Business (105159)
Career Advice (864)
Deals (18487)
Drug Delivery (90)
Drug Development (50611)
Employer Resources (79)
FDA (7628)
Job Trends (7712)
News (185444)
Policy (17287)
Tag
Academia (726)
Alliances (27672)
Alzheimer's disease (557)
Approvals (7593)
Artificial intelligence (80)
Bankruptcy (170)
Best Places to Work (5493)
Biosimilars (67)
Biotechnology (62)
Cancer (519)
Cardiovascular disease (52)
Career advice (702)
Cell therapy (74)
Clinical research (41634)
Collaboration (194)
Compensation (65)
COVID-19 (1070)
C-suite (57)
Data (554)
Diabetes (94)
Diagnostics (1712)
Drug pricing (91)
Earnings (38229)
Employer resources (73)
Events (47483)
Executive appointments (180)
FDA (7872)
Funding (142)
Gene therapy (86)
GLP-1 (480)
Government (1794)
Healthcare (5849)
Infectious disease (1117)
Inflammatory bowel disease (66)
Interviews (114)
IPO (7282)
Job creations (2429)
Job search strategy (644)
Layoffs (251)
Legal (4076)
Lung cancer (92)
Manufacturing (120)
Medical device (1946)
Medtech (1949)
Mergers & acquisitions (11232)
Metabolic disorders (318)
Neuroscience (713)
NextGen Class of 2024 (2346)
Non-profit (900)
Northern California (631)
Obesity (205)
Opinion (174)
Patents (68)
People (32853)
Pharmaceutical (75)
Phase I (12970)
Phase II (17622)
Phase III (14194)
Pipeline (253)
Podcasts (55)
Policy (68)
Postmarket research (1609)
Preclinical (4548)
Radiopharmaceuticals (154)
Rare diseases (129)
Real estate (3164)
Regulatory (12097)
Research institute (815)
Resumes & cover letters (138)
Southern California (587)
Startups (2004)
United States (5806)
Vaccines (210)
Weight loss (181)
Date
Today (102)
Last 7 days (490)
Last 30 days (1772)
Last 365 days (17797)
2024 (15984)
2023 (19635)
2022 (25865)
2021 (26639)
2020 (24871)
2019 (20058)
2018 (15587)
2017 (17253)
2016 (16202)
2015 (18802)
2014 (14787)
2013 (12552)
2012 (13482)
2011 (13817)
2010 (12738)
Location
Africa (406)
Asia (24418)
Australia (3145)
California (1418)
Canada (713)
China (140)
Colorado (61)
Connecticut (55)
Europe (50396)
Florida (192)
Illinois (142)
Indiana (112)
Kansas (56)
Maryland (221)
Massachusetts (1202)
Minnesota (86)
New Jersey (546)
New York (413)
North Carolina (350)
Northern California (631)
Ohio (62)
Pennsylvania (349)
South America (603)
Southern California (587)
Texas (174)
Washington State (139)
327,059 Results for "pherecydes pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
ERYTECH announces that the Commercial Court has rejected Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma
ERYTECH Pharma, announced that the Lyon Commercial Court has rejected Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma.
June 14, 2023
·
4 min read
Deals
ERYTECH Provides Update on the Announced Combination with PHERECYDES
ERYTECH Pharma,aclinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, provided anupdateon the announced combination with PHERECYDES.
May 15, 2023
·
9 min read
Opinion
Opinion: A Small Pharma Mindset Can Reshape Big Pharma and Improve Patient Care
An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.
September 12, 2024
·
3 min read
·
Jill Marie Drury
Genetown
ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes
ERYTECH Pharma announced that Akkadian Partners has initiated legal proceedings to obtain the postponement of the vote on the merger with Pherecydes at the Annual General Meeting on June 23.
June 5, 2023
·
1 min read
Layoffs
Athira Pharma to Lay Off 70% of Workforce
Athira Pharma will cut about 49 positions, including two people in the C-suite. The announcement follows the company’s disappointing results for its investigational Alzheimer’s therapy.
September 23, 2024
·
1 min read
·
Angela Gabriel
Business
Astellas Pharma Opens Cambridge Life Sciences Center Featuring Incubator Space
Astellas Pharma’s new life sciences center houses its first U.S.-based SakuLab, an incubator space for external partners, as well as its engineered small molecules unit.
September 6, 2024
·
1 min read
·
Angela Gabriel
ERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder’s Meeting held on June 23, 2023
ERYTECH Pharma announced that all resolutions for which the Board of Directors recommended a vote in favor,including the approval of the merger with Pherecydes, were adopted by its shareholders at the Combined General Meeting that was held today, June 23, 2023
June 23, 2023
·
7 min read
Mergers & acquisitions
Broken Deals: 4 Pharma Assets Returned to Biotech This Year
Not all licensing deals are successful. Here,
BioSpace
examines a few noteworthy assets that Big Pharma returned in the last 12 months.
August 27, 2024
·
5 min read
·
Mollie Barnes
Deals
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics
ERYTECH (Nasdaq & Euronext: ERYP) and PHERECYDES announce merger and name change to PHAXIAM Therapeutics, a clinical-stage biopharmaceutical company developing innovative extended bacteriophage therapies to target antimicrobial resistance (AMR).
June 26, 2023
·
7 min read
Cell and gene therapy
Big Pharma’s Interest Grows in Evolving Cell and Gene Therapy Sector
Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand their presence in the industry.
October 9, 2024
·
4 min read
·
Greg Slabodkin
1 of 32,706
Next
